Evidence map›Paper›PMID 31856218›Full record

ArticlePLoS pathogens2019

The alternative cap-binding complex is required for antiviral defense in vivo.

Anna Gebhardt, Valter Bergant, Daniel Schnepf, Markus Moser, Arno Meiler, Dieudonnée Togbe, Claire Mackowiak, Line S Reinert, Søren R Paludan, Bernhard Ryffel and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Temperature and developmental stage govern intestinal susceptibility to human coronavirus 229E.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. The Impact ofViruses · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. HIV-1 hypermethylated guanosine cap licenses specialized translation unaffected by mTOR.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Article
  13. Review
  14. NCBP3 positively impacts mRNA biogenesis.Nucleic acids research · 2020
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Anna GebhardtInstitute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.
Valter BergantInstitute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.
Daniel SchnepfInstitute of Virology, University of Freiburg, Freiburg, Germany.ORCID 0000-0002-7528-981X
Markus MoserDepartment of Molecular Medicine, Max-Planck Institute of Biochemistry, Martinsried, Germany.ORCID 0000-0001-8825-5566
Arno MeilerInnate Immunity Laboratory, Max-Planck Institute of Biochemistry, Martinsried, Germany.
Dieudonnée TogbeINEM, Experimental Molecular Immunology, UMR7355 CNRS and University, Orleans, France.
Claire MackowiakINEM, Experimental Molecular Immunology, UMR7355 CNRS and University, Orleans, France.
Line S ReinertDepartment of Biomedicine, University of Aarhus, Aarhus, Denmark.ORCID 0000-0002-8317-0886
Søren R PaludanDepartment of Biomedicine, University of Aarhus, Aarhus, Denmark.
Bernhard RyffelINEM, Experimental Molecular Immunology, UMR7355 CNRS and University, Orleans, France.ORCID 0000-0003-2897-8230
Alexey StukalovInstitute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.
Peter StaeheliInstitute of Virology, University of Freiburg, Freiburg, Germany.ORCID 0000-0001-7057-6177
Andreas PichlmairInstitute of Virology, Technical University of Munich, School of Medicine, Munich, Germany.ORCID 0000-0002-0166-1367
Max Planck Institute of Biochemistry · DECentre National de la Recherche Scientifique · FRAarhus University · DKUniversity of Freiburg · DEGerman Center for Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular response to environmental challenges requires immediate and precise regulation of transcriptional programs. During viral infections, this includes the expression of antiviral genes that are essential to combat the pathogen. Transcribed mRNAs are bound and escorted to the cytoplasm by the cap-binding complex (CBC). We recently identified a protein complex consisting of NCBP1 and NCBP3 that, under physiological conditions, has redundant function to the canonical CBC, consisting of NCBP1 and NCBP2. Here, we provide evidence that NCBP3 is essential to mount a precise and appropriate antiviral response. Ncbp3-deficient cells allow higher virus growth and elicit a reduced antiviral response, a defect happening on post-transcriptional level. Ncbp3-deficient mice suffered from severe lung pathology and increased morbidity after influenza A virus challenge. While NCBP3 appeared to be particularly important during viral infections, it may be more broadly involved to ensure proper protein expression.

Indexed as

AnimalsInfluenza A virusMiceMice, KnockoutOrthomyxoviridae InfectionsProtein BiosynthesisRNA Cap-Binding ProteinsRNA Cap-Binding Proteins

Identifiers

PMID31856218
PMCPMC6946169
OpenAlexW2995788884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.